BioCentury | Jul 7, 2017
Finance

Generalists needed

...TSX:ZYME) 4/27/17 $63.6 $319.7 $211.4 -34% Senhwa Biosciences Inc. (TPEx:6492) 4/24/17 $45.4 $397.5 $299.7 -25% Bora Pharmaceuticals Co. Ltd....
BioCentury | Apr 7, 2017
Finance

Taking notice

...Pharma Inc. 10/11/16 $12M Ph II Aslan Pharmaceuticals Ltd. (TPEx-E:6497) (D) 9/26/16 TBD Ph II Bora Pharmaceuticals Co. Ltd....
BioCentury | Jan 6, 2017
Finance

Good riddance

...KOSDAQ) 9/28/16 W22.1B ($20M) Mkt (vaccine) Aslan Pharmaceuticals Ltd. (TPEx-E:6497) (D) 9/26/16 TBD Ph II Bora Pharmaceuticals Co. Ltd....
BioCentury | Oct 3, 2016
Finance

Reasonable rally

...9/30/16 Up to $172.5M Ph II Aslan Pharmaceuticals Ltd. (TPEx) (C) 9/26/16 TBD Ph II Bora Pharmaceuticals Co. Ltd....
BioCentury | Oct 3, 2016
Financial News

Bora Pharmaceuticals proposes IPO

...2016-09-23 Type: IPO To be raised: TBD Shares: TBD Price: TBD Underwriter: Taishin Securities Note: Bora Pharmaceuticals...
...first trade as an emerging stock for at least six months or meet other requirements. Bora Pharmaceuticals...
BioCentury | Jul 11, 2016
Finance

Ground up

...$16.3M Ph III Viventia Bio Inc. 10/21/15 TBD Ph III AnaptysBio Inc. 9/9/15 TBD Preclin Bora Pharmaceuticals Co. Ltd....
BioCentury | Apr 4, 2016
Finance

Fundamental reset

...10/21/15 TBD Ph III Merus B.V. 10/19/15 TBD Ph I/II AnaptysBio Inc. 9/9/15 TBD Preclin Bora Pharmaceuticals Co. Ltd....
BioCentury | Jan 4, 2016
Finance

Curbed enthusiasm

...II PLx Pharma Inc. 10/5/15 Up to $80.5M Approved (drug) AnaptysBio Inc. 9/9/15 TBD Preclin Bora Pharmaceuticals Co. Ltd....
BioCentury | Oct 5, 2015
Finance

Volatile, not futile

...LSE) 9/7/15 TBD Ph III Shield Therapeutics AG (LSE) 9/7/15 Up to £110M ($167.2M) Registration Bora Pharmaceuticals Co. Ltd....
BioCentury | Sep 7, 2015
Financial News

Bora Pharmaceuticals proposes IPO

...2015-08-31 Type: IPO To be raised: TBD Shares: TBD Price: TBD Underwriter: Taishin Securities Note: Bora Pharmaceuticals...
...first trade as an emerging stock for at least six months and meet other requirements. Bora Pharmaceuticals...
Items per page:
1 - 10 of 11
BioCentury | Jul 7, 2017
Finance

Generalists needed

...TSX:ZYME) 4/27/17 $63.6 $319.7 $211.4 -34% Senhwa Biosciences Inc. (TPEx:6492) 4/24/17 $45.4 $397.5 $299.7 -25% Bora Pharmaceuticals Co. Ltd....
BioCentury | Apr 7, 2017
Finance

Taking notice

...Pharma Inc. 10/11/16 $12M Ph II Aslan Pharmaceuticals Ltd. (TPEx-E:6497) (D) 9/26/16 TBD Ph II Bora Pharmaceuticals Co. Ltd....
BioCentury | Jan 6, 2017
Finance

Good riddance

...KOSDAQ) 9/28/16 W22.1B ($20M) Mkt (vaccine) Aslan Pharmaceuticals Ltd. (TPEx-E:6497) (D) 9/26/16 TBD Ph II Bora Pharmaceuticals Co. Ltd....
BioCentury | Oct 3, 2016
Finance

Reasonable rally

...9/30/16 Up to $172.5M Ph II Aslan Pharmaceuticals Ltd. (TPEx) (C) 9/26/16 TBD Ph II Bora Pharmaceuticals Co. Ltd....
BioCentury | Oct 3, 2016
Financial News

Bora Pharmaceuticals proposes IPO

...2016-09-23 Type: IPO To be raised: TBD Shares: TBD Price: TBD Underwriter: Taishin Securities Note: Bora Pharmaceuticals...
...first trade as an emerging stock for at least six months or meet other requirements. Bora Pharmaceuticals...
BioCentury | Jul 11, 2016
Finance

Ground up

...$16.3M Ph III Viventia Bio Inc. 10/21/15 TBD Ph III AnaptysBio Inc. 9/9/15 TBD Preclin Bora Pharmaceuticals Co. Ltd....
BioCentury | Apr 4, 2016
Finance

Fundamental reset

...10/21/15 TBD Ph III Merus B.V. 10/19/15 TBD Ph I/II AnaptysBio Inc. 9/9/15 TBD Preclin Bora Pharmaceuticals Co. Ltd....
BioCentury | Jan 4, 2016
Finance

Curbed enthusiasm

...II PLx Pharma Inc. 10/5/15 Up to $80.5M Approved (drug) AnaptysBio Inc. 9/9/15 TBD Preclin Bora Pharmaceuticals Co. Ltd....
BioCentury | Oct 5, 2015
Finance

Volatile, not futile

...LSE) 9/7/15 TBD Ph III Shield Therapeutics AG (LSE) 9/7/15 Up to £110M ($167.2M) Registration Bora Pharmaceuticals Co. Ltd....
BioCentury | Sep 7, 2015
Financial News

Bora Pharmaceuticals proposes IPO

...2015-08-31 Type: IPO To be raised: TBD Shares: TBD Price: TBD Underwriter: Taishin Securities Note: Bora Pharmaceuticals...
...first trade as an emerging stock for at least six months and meet other requirements. Bora Pharmaceuticals...
Items per page:
1 - 10 of 11